A Phase 1 Study of BMS-833923 (XL139) in Subjects With Advanced or Metastatic Cancer
| Status: | Archived |
|---|---|
| Conditions: | Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | September 2000 |
| End Date: | December 2013 |
A Phase 1 Multiple Ascending Dose Study of BMS-833923 in Subjects With Advanced or Metastatic Solid Tumors
The purpose of this study is to determine the safety of BMS-833923 (XL139) in patients with
advanced or metastatic cancers and determine the recommended phase 2 dose range and schedule
We found this trial at
4
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Mayo Clinic Rochester Mayo Clinic is a nonprofit worldwide leader in medical care, research and...
Click here to add this to my saved trials
Click here to add this to my saved trials